Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Adherence profiles in kidney transplant patients: Causes and consequences.

Villeneuve C, Rousseau A, Rerolle JP, Couzi L, Kamar N, Essig M, Etienne I, Westeel PF, Büchler M, Esposito L, Thierry A, Marquet P, Monchaud C.

Patient Educ Couns. 2019 Aug 7. pii: S0738-3991(19)30318-0. doi: 10.1016/j.pec.2019.08.002. [Epub ahead of print]

PMID:
31447197
2.

Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.

Kaminski H, Jarque M, Halfon M, Taton B, Di Ascia L, Pfirmann P, Visentin J, Garrigue I, Déchanet-Merville J, Moreau JF, Crespo E, Montero N, Melilli E, Meneghini M, Pascual M, Couzi L, Manuel O, Bestard O, Merville P.

J Infect Dis. 2019 Jul 31;220(5):761-771. doi: 10.1093/infdis/jiz194.

PMID:
31157865
3.

Late vs early-onset CMV infections in kidney transplantation, still a topical issue, reply to Ono et al.

Kaminski H, Couzi L, Merville P.

Transpl Infect Dis. 2019 Aug;21(4):e13103. doi: 10.1111/tid.13103. Epub 2019 May 22. No abstract available.

PMID:
31077514
4.

Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies.

Glotz D, Russ G, Rostaing L, Legendre C, Tufveson G, Chadban S, Grinyó J, Mamode N, Rigotti P, Couzi L, Büchler M, Sandrini S, Dain B, Garfield M, Ogawa M, Richard T, Marks WH; C10-002 Study Group.

Am J Transplant. 2019 Apr 23. doi: 10.1111/ajt.15397. [Epub ahead of print]

PMID:
31012541
5.

C5b9 Deposition in Glomerular Capillaries Is Associated With Poor Kidney Allograft Survival in Antibody-Mediated Rejection.

Goutaudier V, Perrochia H, Mucha S, Bonnet M, Delmas S, Garo F, Garrigue V, Lepreux S, Pernin V, Serre JE, Szwarc I, Merville P, Ramounau-Pigot A, René C, Visentin J, Morgan BP, Frémeaux-Bacchi V, Mourad G, Couzi L, Le Quintrec M.

Front Immunol. 2019 Mar 8;10:235. doi: 10.3389/fimmu.2019.00235. eCollection 2019.

6.

Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors.

Gaillard F, Courbebaisse M, Kamar N, Rostaing L, Jacquemont L, Hourmant M, Del Bello A, Couzi L, Merville P, Malvezzi P, Janbon B, Moulin B, Maillard N, Dubourg L, Lemoine S, Garrouste C, Pottel H, Legendre C, Delanaye P, Mariat C.

Kidney Int. 2019 Apr;95(4):896-904. doi: 10.1016/j.kint.2018.11.029. Epub 2019 Feb 26.

PMID:
30819555
7.

Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study.

Scherlinger M, Carcaud C, Truchetet ME, Barnetche T, Duffau P, Couzi L, Seneschal J, Blanco P, Lazaro E, Richez C.

Ann Rheum Dis. 2019 Jul;78(7):1007-1010. doi: 10.1136/annrheumdis-2018-214833. Epub 2019 Jan 4. No abstract available.

PMID:
30610064
8.

OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.

Jacquemin C, Augusto JF, Scherlinger M, Gensous N, Forcade E, Douchet I, Levionnois E, Richez C, Lazaro E, Duffau P, Truchetet ME, Seneschal J, Couzi L, Pellegrin JL, Viallard JF, Schaeverbeke T, Pascual V, Contin-Bordes C, Blanco P.

JCI Insight. 2018 Dec 20;3(24). pii: 122167. doi: 10.1172/jci.insight.122167.

9.

Complement receptor CD46 co-stimulates optimal human CD8+ T cell effector function via fatty acid metabolism.

Arbore G, West EE, Rahman J, Le Friec G, Niyonzima N, Pirooznia M, Tunc I, Pavlidis P, Powell N, Li Y, Liu P, Servais A, Couzi L, Fremeaux-Bacchi V, Placais L, Ferraro A, Walsh PR, Kavanagh D, Afzali B, Lavender P, Lachmann HJ, Kemper C.

Nat Commun. 2018 Oct 10;9(1):4186. doi: 10.1038/s41467-018-06706-z.

10.

The age-calibrated measured glomerular filtration rate improves living kidney donation selection process.

Gaillard F, Courbebaisse M, Kamar N, Rostaing L, Del Bello A, Girerd S, Kessler M, Flamant M, Vidal-Petiot E, Peraldi MN, Couzi L, Merville P, Malvezzi P, Janbon B, Moulin B, Caillard S, Gatault P, Büchler M, Maillard N, Dubourg L, Roquet O, Garrouste C, Legendre C, Delanaye P, Mariat C.

Kidney Int. 2018 Sep;94(3):616-624. doi: 10.1016/j.kint.2018.05.016.

11.

Two cases of tacrolimus-induced neutropenia: A probably under-diagnosed cause of neutropenia after solid-organ transplantation.

Clément J, Taton B, Merville P, Viallard JF, Lazaro E, Couzi L, Rivière E.

Clin Transplant. 2018 Jul;32(7):e13295. doi: 10.1111/ctr.13295. Epub 2018 Jun 15. No abstract available.

PMID:
29907985
12.

Overcoming non-specific binding to measure the active concentration and kinetics of serum anti-HLA antibodies by surface plasmon resonance.

Visentin J, Couzi L, Dromer C, Neau-Cransac M, Guidicelli G, Veniard V, Coniat KN, Merville P, Di Primo C, Taupin JL.

Biosens Bioelectron. 2018 Oct 15;117:191-200. doi: 10.1016/j.bios.2018.06.013. Epub 2018 Jun 7.

PMID:
29902635
13.

The disappointing contribution of anti-human leukocyte antigen donor-specific antibodies characteristics for predicting allograft loss.

Courant M, Visentin J, Linares G, Dubois V, Lepreux S, Guidicelli G, Thaunat O, Merville P, Couzi L, Taupin JL.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1872. doi: 10.1093/ndt/gfy182. No abstract available.

PMID:
29897514
14.

Increased risk of mortality in systemic sclerosis-associated digital ulcers: a systematic review and meta-analysis.

Meunier P, Dequidt L, Barnetche T, Lazaro E, Duffau P, Richez C, Couzi L, Truchetet ME, Seneschal J; FHU ACRONIM.

J Eur Acad Dermatol Venereol. 2019 Feb;33(2):405-409. doi: 10.1111/jdv.15114. Epub 2018 Jul 17.

PMID:
29888406
15.

Impact of the individualized risks of end-stage renal disease on living kidney donor selection.

Nguyen QL, Merville P, Couzi L.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2245-2252. doi: 10.1093/ndt/gfy145.

PMID:
29846692
16.

The disappointing contribution of anti-human leukocyte antigen donor-specific antibodies characteristics for predicting allograft loss.

Courant M, Visentin J, Linares G, Dubois V, Lepreux S, Guidicelli G, Thaunat O, Merville P, Couzi L, Taupin JL.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1853-1863. doi: 10.1093/ndt/gfy088. Erratum in: Nephrol Dial Transplant. 2018 Oct 1;33(10):1872.

PMID:
29672702
17.

Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays.

Guidicelli G, Visentin J, Franchini N, Borg C, Merville P, Couzi L, Taupin JL.

HLA. 2018 Jun;91(6):507-513. doi: 10.1111/tan.13263.

PMID:
29604172
18.

Prolonged dialysis duration is associated with graft failure and mortality after kidney transplantation: results from the French transplant database.

Prezelin-Reydit M, Combe C, Harambat J, Jacquelinet C, Merville P, Couzi L, Leffondré K.

Nephrol Dial Transplant. 2019 Mar 1;34(3):538-545. doi: 10.1093/ndt/gfy039.

PMID:
29579221
19.

Proliferative lupus nephritis in the absence of overt systemic lupus erythematosus: A historical study of 12 adult patients.

Touzot M, Terrier CS, Faguer S, Masson I, François H, Couzi L, Hummel A, Quellard N, Touchard G, Jourde-Chiche N, Goujon JM, Daugas E; Groupe Coopératif sur le Lupus Rénal (GCLR).

Medicine (Baltimore). 2017 Dec;96(48):e9017. doi: 10.1097/MD.0000000000009017.

20.

Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.

Ruiz-Irastorza G, Ugarte A, Saint-Pastou Terrier C, Lazaro E, Iza A, Couzi L, Saenz R, Richez C, Porta S, Blanco P.

Autoimmun Rev. 2017 Aug;16(8):826-832. doi: 10.1016/j.autrev.2017.05.017. Epub 2017 May 28.

PMID:
28564619
21.

Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay.

Visentin J, Bachelet T, Borg C, Franchini N, Nong T, Lee JH, Couzi L, Merville P, Guidicelli G, Taupin JL.

Transplantation. 2017 Mar;101(3):624-630. doi: 10.1097/TP.0000000000001239.

PMID:
27336398
22.

IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.

Khoryati L, Augusto JF, Shipley E, Contin-Bordes C, Douchet I, Mitrovic S, Truchetet ME, Lazaro E, Duffau P, Couzi L, Jacquemin C, Barnetche T, Vacher P, Schaeverbeke T, Blanco P, Richez C; Fédération Hospitalo-Universitaire ACRONIM.

Arthritis Rheumatol. 2016 Sep;68(9):2221-31. doi: 10.1002/art.39679.

23.

Easier Control of Late-Onset Cytomegalovirus Disease Following Universal Prophylaxis Through an Early Antiviral Immune Response in Donor-Positive, Recipient-Negative Kidney Transplants.

Kaminski H, Couzi L, Garrigue I, Moreau JF, Déchanet-Merville J, Merville P.

Am J Transplant. 2016 Aug;16(8):2384-94. doi: 10.1111/ajt.13781. Epub 2016 Apr 8. Erratum in: Am J Transplant. 2017 Feb;17 (2):588-589.

24.

Deciphering IgM interference in IgG anti-HLA antibody detection with flow beads assays.

Visentin J, Guidicelli G, Couzi L, Merville P, Lee JH, Di Primo C, Taupin JL.

Hum Immunol. 2016 Nov;77(11):1048-1054. doi: 10.1016/j.humimm.2016.02.008. Epub 2016 Feb 20.

PMID:
26902993
25.

Cytomegalovirus-Induced γδ T Cells During Rejection: An Ambivalent T Cell.

Bachelet T, Merville P, Dechanet-Merville J, Couzi L.

Am J Transplant. 2016 Jan;16(1):368-9. doi: 10.1111/ajt.13568. No abstract available.

26.

Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review.

Contis A, Vanquaethem H, Truchetet ME, Couzi L, Rigothier C, Richez C, Lazaro E, Duffau P.

Clin Rheumatol. 2016 Feb;35(2):517-22. doi: 10.1007/s10067-015-3166-9. Epub 2016 Jan 14.

PMID:
26762196
27.

Anti-HLA donor-specific antibodies are not created equally. Don't forget the flow….

Bachelet T, Visentin J, Guidicelli G, Merville P, Couzi L, Taupin JL.

Transpl Int. 2016 Apr;29(4):508-10. doi: 10.1111/tri.12745. Epub 2016 Feb 17. No abstract available.

28.

Quelle valeur accorder à l'IMC dans l'évaluation de la morbidité périopératoire de la transplantation rénale ?

Queruel V, Kabore R, Guillaume A, Moreau K, Leffondre K, Couzi L, Quinart A, Rogier J, Tauzin-Fin P, Merville P, Robert G, Pasticier G, Bensadoun H, Ferrière J, Bernhard J.

Prog Urol. 2015 Nov;25(13):764-5. doi: 10.1016/j.purol.2015.08.101. French. No abstract available.

PMID:
26544295
29.

Evaluation of the iBeads assay as a tool for identifying class I HLA antibodies.

Visentin J, Guidicelli G, Nong T, Moreau JF, Merville P, Couzi L, Lee JH, Taupin JL.

Hum Immunol. 2015 Sep;76(9):651-6. doi: 10.1016/j.humimm.2015.09.012. Epub 2015 Sep 25.

PMID:
26407911
30.

Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.

Bachelet T, Martinez C, Del Bello A, Couzi L, Kejji S, Guidicelli G, Lepreux S, Visentin J, Congy-Jolivet N, Rostaing L, Taupin JL, Kamar N, Merville P.

Transplantation. 2016 Jan;100(1):159-66. doi: 10.1097/TP.0000000000000821.

PMID:
26262501
31.

[Immunomonitoring for cytomegalovirus infection in kidney transplantation: Development and prospects].

Kaminski H, Couzi L, Déchanet-Merville J, Merville P.

Nephrol Ther. 2015 Nov;11(6):465-73. doi: 10.1016/j.nephro.2015.03.005. Epub 2015 Jul 21. Review. French.

PMID:
26206770
32.

TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance.

Guerville F, Daburon S, Marlin R, Lartigue L, Loizon S, Pitard V, Couzi L, Moreau JF, Déchanet-Merville J, Faustin B.

Oncoimmunology. 2015 Feb 3;4(5):e1003011. eCollection 2015 May.

33.

Incidence and Outcome of C4d Staining With Tubulointerstitial Inflammation in Blood Group-incompatible Kidney Transplantation.

Couzi L, Perera R, Manook M, Barnett AN, Shaw O, Kessaris N, Marks SD, Dorling A, Mamode N.

Transplantation. 2015 Jul;99(7):1487-94. doi: 10.1097/TP.0000000000000556.

PMID:
26151608
34.

Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations.

Couzi L, Manook M, Perera R, Shaw O, Ahmed Z, Kessaris N, Dorling A, Mamode N.

Transpl Int. 2015 Oct;28(10):1205-15. doi: 10.1111/tri.12621. Epub 2015 Jul 6.

35.

Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses.

Kolev M, Dimeloe S, Le Friec G, Navarini A, Arbore G, Povoleri GA, Fischer M, Belle R, Loeliger J, Develioglu L, Bantug GR, Watson J, Couzi L, Afzali B, Lavender P, Hess C, Kemper C.

Immunity. 2015 Jun 16;42(6):1033-47. doi: 10.1016/j.immuni.2015.05.024.

36.

OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.

Jacquemin C, Schmitt N, Contin-Bordes C, Liu Y, Narayanan P, Seneschal J, Maurouard T, Dougall D, Davizon ES, Dumortier H, Douchet I, Raffray L, Richez C, Lazaro E, Duffau P, Truchetet ME, Khoryati L, Mercié P, Couzi L, Merville P, Schaeverbeke T, Viallard JF, Pellegrin JL, Moreau JF, Muller S, Zurawski S, Coffman RL, Pascual V, Ueno H, Blanco P.

Immunity. 2015 Jun 16;42(6):1159-70. doi: 10.1016/j.immuni.2015.05.012. Epub 2015 Jun 9.

37.

Surveillance of γδ T Cells Predicts Cytomegalovirus Infection Resolution in Kidney Transplants.

Kaminski H, Garrigue I, Couzi L, Taton B, Bachelet T, Moreau JF, Déchanet-Merville J, Thiébaut R, Merville P.

J Am Soc Nephrol. 2016 Feb;27(2):637-45. doi: 10.1681/ASN.2014100985. Epub 2015 Jun 8.

38.

Two-year post-transplantation cytomegalovirus DNAemia in asymptomatic kidney transplant recipients: incidence, risk factors, and outcome.

Viot B, Garrigue I, Taton B, Bachelet T, Moreau JF, Dechanet-Merville J, Merville P, Couzi L.

Transpl Infect Dis. 2015 Aug;17(4):497-509. doi: 10.1111/tid.12408. Epub 2015 Jul 7.

PMID:
26052675
39.

Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival.

Guidicelli G, Guerville F, Lepreux S, Wiebe C, Thaunat O, Dubois V, Visentin J, Bachelet T, Morelon E, Nickerson P, Merville P, Taupin JL, Couzi L.

J Am Soc Nephrol. 2016 Feb;27(2):615-25. doi: 10.1681/ASN.2014040326. Epub 2015 Jun 5.

40.

Embolization of renal arteries before transplantation in patients with polycystic kidney disease: a single institution long-term experience.

Petitpierre F, Cornelis F, Couzi L, Lasserre AS, Tricaud E, Le Bras Y, Merville P, Combe C, Ferriere JM, Grenier N.

Eur Radiol. 2015 Nov;25(11):3263-71. doi: 10.1007/s00330-015-3730-3. Epub 2015 May 17.

PMID:
25981217
41.

Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody-mediated rejection: a pilot study.

Bachelet T, Nodimar C, Taupin JL, Lepreux S, Moreau K, Morel D, Guidicelli G, Couzi L, Merville P.

Clin Transplant. 2015 May;29(5):439-46. doi: 10.1111/ctr.12535. Epub 2015 Mar 30.

PMID:
25739833
42.

Clinical impact of preformed donor-specific denatured class I HLA antibodies after kidney transplantation.

Visentin J, Marroc M, Guidicelli G, Bachelet T, Nong T, Moreau JF, Lee JH, Merville P, Couzi L, Taupin JL.

Clin Transplant. 2015 May;29(5):393-402. doi: 10.1111/ctr.12529. Epub 2015 Mar 13.

PMID:
25683727
43.

Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation.

Couzi L, Pitard V, Moreau JF, Merville P, Déchanet-Merville J.

Front Immunol. 2015 Jan 21;6:3. doi: 10.3389/fimmu.2015.00003. eCollection 2015. Review.

44.

Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocation.

Visentin J, Guidicelli G, Bachelet T, Jacquelinet C, Audry B, Nong T, Dubois V, Moreau JF, Lee JH, Couzi L, Merville P, Taupin JL.

Transplantation. 2014 Oct 15;98(7):738-44. doi: 10.1097/TP.0000000000000229.

PMID:
25289917
45.

Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.

Sicard A, Ducreux S, Rabeyrin M, Couzi L, McGregor B, Badet L, Scoazec JY, Bachelet T, Lepreux S, Visentin J, Merville P, Fremeaux-Bacchi V, Morelon E, Taupin JL, Dubois V, Thaunat O.

J Am Soc Nephrol. 2015 Feb;26(2):457-67. doi: 10.1681/ASN.2013101144. Epub 2014 Aug 14.

46.

Lateral incisional hernia after renal transplantation: a comparative study.

Luc G, David A, Couzi L, Midy D, Collet D, Dubuisson V.

World J Surg. 2014 Nov;38(11):2791-6. doi: 10.1007/s00268-014-2689-6.

PMID:
25015726
47.

Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions.

Bachelet T, Couzi L, Pitard V, Sicard X, Rigothier C, Lepreux S, Moreau JF, Taupin JL, Merville P, Déchanet-Merville J.

J Am Soc Nephrol. 2014 Nov;25(11):2471-82. doi: 10.1681/ASN.2013101052. Epub 2014 Apr 17.

48.

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, Coilly A, Garrigue V, D'Alteroche L, Buchler M, Couzi L, Lebray P, Dharancy S, Minello A, Hourmant M, Roque-Afonso AM, Abravanel F, Pol S, Rostaing L, Mallet V.

N Engl J Med. 2014 Mar 20;370(12):1111-20. doi: 10.1056/NEJMoa1215246.

49.

Body composition in 98 patients awaiting kidney transplantation.

Moreau K, Desseix A, Germain C, Barthe N, Bachelet T, Morel D, Merville P, Couzi L, Thiebaut R, Chauveau P.

Nutrition. 2014 Feb;30(2):186-91. doi: 10.1016/j.nut.2013.07.018.

PMID:
24377453
50.

Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation.

Taton B, Moreau K, Lepreux S, Bachelet T, Trimoulet P, De Ledinghen V, Pommereau A, Ronco P, Kamar N, Merville P, Couzi L.

Transpl Infect Dis. 2013 Dec;15(6):E211-5. doi: 10.1111/tid.12143. Epub 2013 Sep 18.

PMID:
24103101

Supplemental Content

Support Center